Skip to main content
Medexus Pharmaceuticals Inc. logo

Medexus Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · MDP LEI · 8945002TBEYY0HLH1M19 TSX Manufacturing
Open in API
Filings indexed 325 across all filing types
Latest filing 2026-04-15 Capital/Financing Update
Country CA Canada
Listing TSX MDP

About Medexus Pharmaceuticals Inc.

https://www.medexus.com/en_US

Medexus Pharmaceuticals, Inc. is an innovative specialty pharmaceutical company engaged in the development and commercialization of treatment solutions. The company utilizes a highly scalable North American business model, leveraging a fully integrated infrastructure encompassing commercial operations, supply chain, regulatory affairs, and a dedicated salesforce. Medexus focuses on building a portfolio of specialty and rare disease products across key therapeutic areas, including hematology, hematology-oncology, allergy, dermatology, and rheumatology. Its mission is to deliver quality healthcare products to patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a news release providing an operational business update on product commercialization, plus details on recent capital allocation and capital structure developments (notably share repurchases under the NCIB and warrant expirations), and mentions investor conference participation. It is not a formal interim or annual report, call transcript, or proxy filing. The focus on capital structure updates and financing activities aligns with the Capital/Financing Update category (CAP).
2026-04-15 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 52-109F2', which is a standard officer certification of interim filings. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference interim reports, should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. Q3 2025
2026-02-11 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109F2, which is an officer certification of interim filings. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type (like interim filings), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. Q3 2025
2026-02-11 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document contains 'Condensed Interim Consolidated Financial Statements' for the three- and nine-month periods ended December 31, 2025. It includes detailed financial tables such as the Statement of Financial Position, Statement of Income, and Statement of Changes in Shareholders' Equity. Since it provides comprehensive financial data for an interim period rather than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). 9M 2026
2026-02-11 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is explicitly titled 'Management's Discussion & Analysis' and covers the three- and nine-month periods ended December 31, 2025. It contains detailed sections on operations, liquidity, capital resources, and risk factors, which are characteristic of an MD&A report. It is not an announcement of a report (RPA) because it contains the full content of the analysis rather than just a summary or notification of availability.
2026-02-11 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release announcing the scheduling of a future conference call to discuss financial results. It does not contain the actual financial results or the report itself, but rather provides details on how to access the upcoming call and the expected filing date of the financial statements. According to the 'Menu vs Meal' rule, this is an announcement regarding the timing of a report/event, which fits the Report Publication Announcement (RPA) category. Q3 2026
2026-02-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.